Treatment with recombinant activated factor VII in a patient with hemophilia A and an inhibitor: advantages of administration by continuous infusion over bolus intermittent injections.

Scaraggi, F A

Treatment with recombinant activated factor VII in a patient with hemophilia A and an inhibitor: advantages of administration by continuous infusion over bolus intermittent injections. [electronic resource] - Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis Jan 1999 - 33-8 p. digital

Publication Type: Case Reports; Journal Article

0957-5235

10.1097/00001721-199901000-00005 doi


Adult
Antibodies--blood
Factor VIIa--administration & dosage
Hemophilia A--blood
Humans
Infusions, Intravenous
Injections, Intravenous
Male
Recombinant Proteins--administration & dosage